• SPX
  • $5,948.71
  • 0.53 %
  • $31.60
  • DJI
  • $43,870.35
  • 1.06 %
  • $461.88
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,205.88
  • 0.69 %
  • $56.61
  • IXIC
  • $18,972.42
  • 0.03 %
  • $6.28
Harmony Biosciences Holdings, Inc. (HRMY) Stock Price, News & Analysis

Harmony Biosciences Holdings, Inc. (HRMY) Stock Price, News & Analysis

Currency in USD Disclaimer

$33.25

$0.46

(1.4%)

Day's range
$32.33
Day's range
$33.31
50-day range
$31.02
Day's range
$41.61
  • Country: US
  • ISIN: US4131971040
52 wk range
$28.14
Day's range
$41.61
  • CEO: Dr. Jeffrey M. Dayno M.D.
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 5.20
  • Piotroski Score 7.00
  • Grade Buy
  • Symbol (HRMY)
  • Company Harmony Biosciences Holdings, Inc.
  • Price $33.25
  • Changes Percentage (1.4%)
  • Change $0.46
  • Day Low $32.33
  • Day High $33.31
  • Year High $41.61

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 02/19/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $52.00
  • High Stock Price Target $61.00
  • Low Stock Price Target $28.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $2.32
  • Trailing P/E Ratio 13.15
  • Forward P/E Ratio 13.15
  • P/E Growth 13.15
  • Net Income $128.85 M

Income Statement

Quarterly

Annual

Latest News of HRMY

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Harmony Biosciences Holdings, Inc. Frequently Asked Questions

  • What were the earnings of HRMY in the last quarter?

    In the last quarter Harmony Biosciences Holdings, Inc. earnings were on Tuesday, October, 29th. The Harmony Biosciences Holdings, Inc. maker reported $0.79 EPS for the quarter, beating analysts' consensus estimates of $0.67 by $0.12.

  • What is the Harmony Biosciences Holdings, Inc. stock price today?

    Today's price of Harmony Biosciences Holdings, Inc. is $33.25 — it has increased by +1.4% in the past 24 hours. Watch Harmony Biosciences Holdings, Inc. stock price performance more closely on the chart.

  • Does Harmony Biosciences Holdings, Inc. release reports?

    Yes, you can track Harmony Biosciences Holdings, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Harmony Biosciences Holdings, Inc. stock forecast?

    Watch the Harmony Biosciences Holdings, Inc. chart and read a more detailed Harmony Biosciences Holdings, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Harmony Biosciences Holdings, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Harmony Biosciences Holdings, Inc. stock ticker.

  • How to buy Harmony Biosciences Holdings, Inc. stocks?

    Like other stocks, HRMY shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Harmony Biosciences Holdings, Inc.'s EBITDA?

    Harmony Biosciences Holdings, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Harmony Biosciences Holdings, Inc.’s financial statements.

  • What is the Harmony Biosciences Holdings, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0.2213885386, which equates to approximately 22.14%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Harmony Biosciences Holdings, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Harmony Biosciences Holdings, Inc.'s financials relevant news, and technical analysis. Harmony Biosciences Holdings, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Harmony Biosciences Holdings, Inc. stock currently indicates a “sell” signal. For more insights, review Harmony Biosciences Holdings, Inc.’s technical analysis.

  • A revenue figure for Harmony Biosciences Holdings, Inc. for its last quarter?

    Harmony Biosciences Holdings, Inc. published it's last quarterly revenues at $186.04 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.